| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 04/10/2002 | EP1194228A1 Affinity-controlling material with the use of stimulus-responsive polymer and separation/purification method with the use of the material |
| 04/10/2002 | EP1037537B1 A process for preparing a kappa-caseino glycomacropeptide or a derivative thereof |
| 04/10/2002 | CN1344370A Protein isolation and analysis |
| 04/10/2002 | CN1344273A Method for drying protein crystals |
| 04/10/2002 | CN1344248A Method for acylating peptides and novel acylating agents |
| 04/09/2002 | US6369028 For combatting endoparasites |
| 04/09/2002 | US6368800 Kits for isolating biological target materials using silica magnetic particles |
| 04/09/2002 | US6368619 Hydrophobic preparations of hydrophilic species and process for their preparation |
| 04/09/2002 | US6368509 Device for dialysis/purification of proteins |
| 04/09/2002 | US6368402 Filling an oil in crystallization wells, providing a cocktail and protein solutions that co-dilute, incubating, inspecting, scoring the results |
| 04/09/2002 | CA2298572C Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/09/2002 | CA2093219C Amides of antibiotic ge 2270 factors |
| 04/09/2002 | CA2083271C Fibrin binding domain polypeptides and uses and methods of producing same |
| 04/04/2002 | WO2002027317A2 Conjugates of defined stoichiometry |
| 04/04/2002 | WO2002027315A2 Compounds with a branched linker |
| 04/04/2002 | WO2002026998A2 Hydrolases |
| 04/04/2002 | WO2002026982A2 Secreted human proteins |
| 04/04/2002 | WO2002026781A2 Ige receptor antagonists |
| 04/04/2002 | WO2002026777A1 Peptide ligands for prostate specific antigen |
| 04/04/2002 | WO2002026773A1 Electrophoresis system |
| 04/04/2002 | WO2002026772A1 Method for the selective modification of peptides and proteins |
| 04/04/2002 | WO2001096282B1 Method for producing amides or esters |
| 04/04/2002 | WO2001092466A3 Chemical reagents for formation of disulfide bonds in peptides |
| 04/04/2002 | WO2001088532A3 Improved assay techniques using nematode worms |
| 04/04/2002 | WO2001085796A3 Use of inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumour formation and/or vascular leakage |
| 04/04/2002 | WO2001079462A3 Nucleic acids encoding polypeptides having haloperoxidase activity |
| 04/04/2002 | WO2001032694A3 Method for characterising and separating molecular associates |
| 04/04/2002 | US20020039774 Anticholesterol agents |
| 04/04/2002 | US20020039747 Protein separation; genetic mapping |
| 04/04/2002 | US20020039723 Biocatalytic methods for synthesizing and identifying biologically active compounds |
| 04/04/2002 | US20020038787 Filtration |
| 04/04/2002 | CA2423966A1 Peptide ligands for prostate specific antigen |
| 04/04/2002 | CA2423953A1 Hydrolases |
| 04/04/2002 | CA2423424A1 Secreted proteins |
| 04/04/2002 | CA2421676A1 Method for the selective modification of peptides and proteins |
| 04/04/2002 | CA2420475A1 Ige receptor antagonists |
| 04/03/2002 | EP1192180A1 Product from starfish |
| 04/03/2002 | EP1192119A2 Process for the preparation of 3,3-dimethylbutanal |
| 04/03/2002 | EP0723536B1 An aglucone isoflavone enriched vegetable protein whey, whey protein, and process for producing |
| 04/03/2002 | EP0722458B1 Peralkylated oligopeptide mixtures |
| 04/03/2002 | CN1343220A Method for producing cyclo-(Asp-Dphe-NMeval-Arg-Gly) |
| 04/02/2002 | US6365395 Process for removing protein aggregates and virus from a protein solution |
| 04/02/2002 | US6365359 Identifying prp pharmacore by determining functional residues of protein involved in complex interactions, developing three dimensional structures, comparing them with other compounds and identifying compounds consistent with binding to protein |
| 04/02/2002 | US6365344 Screening library of randomized nucleic acids using retroviral vectors to transfect mammalian cells, expressing as extracellular bioactive peptides, contacting other mammalian cells, and screening for changed physiology |
| 04/02/2002 | CA1341354C Anticoagulant peptide alcohols |
| 03/28/2002 | WO2002025504A2 Method, system, and computer program product for encoding and building products of a virtual combinatorial library |
| 03/28/2002 | WO2002024924A2 Protein phosphatases |
| 03/28/2002 | WO2001085757A3 Purification of protein inclusion bodies by crossflow microfiltration |
| 03/28/2002 | WO2001083522A3 Growth factor modified protein matrices for tissue engineering |
| 03/28/2002 | WO2001081365A3 Metal chelating compositions |
| 03/28/2002 | WO2001079459A3 Polypeptides having haloperoxidase activity |
| 03/28/2002 | WO2001077170A3 Multiprotein-complexes comprising a nmda receptor and uses thereof |
| 03/28/2002 | WO2001062772A3 Self-encoded combinatorial synthesis of compound multiplets |
| 03/28/2002 | WO2001033438A3 Method for generating information related to the molecular structure of a biomolecule |
| 03/28/2002 | WO2000063419A9 Combinatorial chemical library supports having indicia at coding positions and methods of use |
| 03/28/2002 | WO2000049417A9 Methods for substrate-ligand interaction screening |
| 03/28/2002 | US20020038017 Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| 03/28/2002 | US20020038000 Systematic polypeptide evolution by reverse translation |
| 03/28/2002 | US20020037998 For therapy of hepatitis C virus (HCV) infection |
| 03/28/2002 | US20020037908 For solubilizing a conformationally altered protein, comprising a carboxylic acid anion of picolinic acid, its analogs, or derivatives thereof and a cation; treating Alzheimer's disease or Creutzfelds-Jakob disease for example |
| 03/28/2002 | US20020037529 Use of 13C nuclear magnetic resonance to detect binding to target molecules |
| 03/28/2002 | DE10043369A1 Verfahren und Funktionspartikel zur Durchführung chemischer oder biologischer Reaktionen oder Synthesen Procedures and functional particles for carrying out chemical or biological reactions or syntheses |
| 03/28/2002 | DE10042447A1 Protein aus dem Darm von Wirbeltieren, welches Cholesterin absorbiert, sowie Verwendung dieses Proteins zur Identifizierung von Inhibitoren des intestinalen Cholesterintransports Protein from the intestines of vertebrates, which absorbs cholesterol, as well as use of this protein for the identification of inhibitors of intestinal cholesterol transport |
| 03/28/2002 | CA2420862A1 Protein phosphatases |
| 03/27/2002 | EP1190364A2 System and method for polymer notation |
| 03/27/2002 | EP1190255A1 Epitopes formed by non-covalent association of conjugates |
| 03/27/2002 | EP1190059A1 Sgip peptides |
| 03/27/2002 | EP1189971A2 Functional poly-alpha-aminoacid derivatives useful for the modification of biologically active materials and their application |
| 03/27/2002 | EP1189937A1 Purified antigen for alzheimer's disease, and methods of obtaining and using same |
| 03/27/2002 | EP1189935A1 Extraction of integral membrane proteins |
| 03/27/2002 | EP1189934A2 Oligomeric chaperone proteins |
| 03/27/2002 | EP1189932A1 Novel echinocandin derivatives, method for preparing same and use as antifungal agents |
| 03/27/2002 | EP1189929A2 Factor viia inhibitors |
| 03/27/2002 | EP1189928A1 Methods and compositions for controlled polypeptide synthesis |
| 03/27/2002 | EP1189927A1 Process for the preparation of supports for solid phase synthesis |
| 03/27/2002 | EP1189926A2 Rapid dehydration of proteins |
| 03/27/2002 | EP1042060B1 Method and apparatus for chemical synthesis |
| 03/27/2002 | EP0730470B1 Improved interferon polymer conjugates |
| 03/27/2002 | CN1342200A Crystalline TNF-alpha-converting enzyme and uses thereof |
| 03/27/2002 | CN1342198A Method for rapidly obtaining crystals with desirable morphologies |
| 03/27/2002 | CN1341713A Extraction method of crataegus fruit SOD |
| 03/26/2002 | USRE37606 Capillary electrophoresis using replaceable gels |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362319 Glial cell line-derived neurotrophic factor |
| 03/26/2002 | US6361974 Exonuclease-mediated nucleic acid reassembly in directed evolution |
| 03/26/2002 | US6361964 Increasing disulfide ond formation in proteins by denaturing the proteins, renaturing the protein in the presence of eurkaryotic ecro-1 polypeptide, which promotes disulfide bound formation |
| 03/26/2002 | US6361777 Method of coupling polysaccharides to proteins |
| 03/26/2002 | CA2176670C 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics |
| 03/21/2002 | WO2002022684A2 Transporters and ion channels |
| 03/21/2002 | WO2002022653A1 Method of constructing three-dimensional structure of transmembrane protein |
| 03/21/2002 | WO2002022553A2 Non-natural basic amino acids, their preparation and use |
| 03/21/2002 | WO2001098324A8 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 03/21/2002 | WO2001079267A3 A glycopeptide and preparation thereof |
| 03/21/2002 | WO2001068861A3 THREE-DIMENSIONAL MODEL OF A Fc REGION OF AN IgE ANTIBODY AND USES THEREOF |
| 03/21/2002 | WO2001068664A3 Mass labels |
| 03/21/2002 | WO2001037191A3 Method for manipulating protein or dna sequence data (in order to generate complementary peptide ligands) |
| 03/21/2002 | US20020035243 Drug complexes |
| 03/21/2002 | US20020035241 Process for the separation and/or isolation of plasma proteins by means of annular chromatography |
| 03/21/2002 | US20020035063 Derivatives of laspartomycin and preparation and use thereof |
| 03/21/2002 | US20020035062 Process for the preparation of a protein solution |